26 related articles for article (PubMed ID: 24323909)
1. Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells.
Hau PM; Tsang CM; Yip YL; Huen MS; Tsao SW
PLoS One; 2011; 6(6):e21176. PubMed ID: 21701587
[TBL] [Abstract][Full Text] [Related]
2. Lanthanide-Based Peptide-Directed Visible/Near-Infrared Imaging and Inhibition of LMP1.
Chau HF; Wu Y; Fok WY; Thor W; Cho WC; Ma P; Lin J; Mak NK; Bünzli JG; Jiang L; Long NJ; Lung HL; Wong KL
JACS Au; 2021 Jul; 1(7):1034-1043. PubMed ID: 34467347
[TBL] [Abstract][Full Text] [Related]
3. Antisense therapeutics in oncology: current status.
Farooqi AA; Rehman ZU; Muntane J
Onco Targets Ther; 2014; 7():2035-42. PubMed ID: 25395862
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of siRNA and DNAzymes in cancer.
Karnati HK; Yalagala RS; Undi R; Pasupuleti SR; Gutti RK
Tumour Biol; 2014 Oct; 35(10):9505-21. PubMed ID: 25149153
[TBL] [Abstract][Full Text] [Related]
5. DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma.
Lu ZX; Ma XQ; Yang LF; Wang ZL; Zeng L; Li ZJ; Li XN; Tang M; Yi W; Gong JP; Sun LQ; Cao Y
Cancer Lett; 2008 Jul; 265(2):226-38. PubMed ID: 18353539
[TBL] [Abstract][Full Text] [Related]
6. EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model.
Ke X; Yang YC; Hong SL
Med Oncol; 2011 Dec; 28 Suppl 1():S326-32. PubMed ID: 20862567
[TBL] [Abstract][Full Text] [Related]
7. Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis.
Lu ZX; Ye M; Yan GR; Li Q; Tang M; Lee LM; Sun LQ; Cao Y
Cancer Gene Ther; 2005 Jul; 12(7):647-54. PubMed ID: 15803142
[TBL] [Abstract][Full Text] [Related]
8. [Effect of Epstein-Barr virus latent membrane protein 1 (LMP1) on apoptosis of nasopharyngeal carcinoma cell line CNE1].
Chen Y; Chen XY
Ai Zheng; 2002 May; 21(5):498-503. PubMed ID: 12452040
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence visualization screening for EBV-LMP1-targeted DNAzymes.
You X; Yang YC; Ke X; Hong SL; Hu GH
Otolaryngol Head Neck Surg; 2014 Feb; 150(2):251-8. PubMed ID: 24323909
[TBL] [Abstract][Full Text] [Related]
10. A therapeutic approach to nasopharyngeal carcinomas by DNAzymes targeting EBV LMP-1 gene.
Yang L; Lu Z; Ma X; Cao Y; Sun LQ
Molecules; 2010 Sep; 15(9):6127-39. PubMed ID: 20877211
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma.
Yoshizaki T; Kondo S; Wakisaka N; Murono S; Endo K; Sugimoto H; Nakanishi S; Tsuji A; Ito M
Cancer Lett; 2013 Aug; 337(1):1-7. PubMed ID: 23689138
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]